Quay Steven C

Quay Steven C is listed in filings as President & CEO at Atossa Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 31, 2026, including purchase activity. Recent filings connect the profile to Atossa Therapeutics, Inc. (ATOS). The current snapshot covers public activity from Jul 1, 2024 to Mar 31, 2026. Reported amounts are shown as $572.9K to $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.